Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02939950 · ClinicalTrials.gov registry record · NA
Silicone Hydrogel Soft Contact Lens 7-Day Extended Wear Basis
A NA study, sponsored by Bausch Health Americas.
- Completed
- Registry status
- NA
- Development phase
- 816
- Enrollment target
NCT02939950 is a NA study that has completed, run by Bausch Health Americas. The registered enrollment target is 816 participants.
The verdict
NCT02939950, a NA study, has completed, sponsored by Bausch Health Americas.
- COMPLETED
- Registry status
- NA
- Development phase
- 816 participants
- Enrollment target
Study Summary
The objective of this study is to evaluate the safety and effectiveness of the Bausch + Lomb samfilcon A soft (hydrophilic) contact lens, a new silicone hydrogel contact lens, compared to the Bausch + Lomb PureVision® soft contact lens when worn for 7-day extended wear by adapted soft contact lens wearers.
Interventions
- DEVICE Bausch + Lomb Samfilcon A Soft Contact Lens
- DEVICE Bausch + Lomb Pure Vision Soft Contact Lens
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 816 participants |
| Start Date | 2015-04-30 |
| Est. Completion | 2016-08-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02939950
The ClinicalTrials.gov registry entry for NCT02939950 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 816 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bausch Health Americas, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Bausch + Lomb Samfilcon A Soft Contact Lens is the first listed.
NCT02939950 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02939950 about?
NCT02939950 is a clinical study titled "Silicone Hydrogel Soft Contact Lens 7-Day Extended Wear Basis". The objective of this study is to evaluate the safety and effectiveness of the Bausch + Lomb samfilcon A soft (hydrophilic) contact lens, a new silicone hydrogel contact lens, compared to the Bausch + Lomb PureVision® soft contact lens when worn for 7-day extended wear by adapted soft contact lens w...
What is the current status of trial NCT02939950?
This trial is currently completed. It is a NA study. The enrollment target is 816 participants. The study started on 2015-04-30. Estimated completion is 2016-08-03.
What interventions are being tested in trial NCT02939950?
The interventions under investigation include: Bausch + Lomb Samfilcon A Soft Contact Lens (DEVICE), Bausch + Lomb Pure Vision Soft Contact Lens (DEVICE).
Who is sponsoring clinical trial NCT02939950?
This trial is sponsored by Bausch Health Americas, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.